WuXi Biologics (Cayman) (WuXi Biologics (Cayman)) Days Sales Outstanding

: 103.51 (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

WuXi Biologics (Cayman)'s average Accounts Receivable for the six months ended in Jun. 2023 was $673 Mil. WuXi Biologics (Cayman)'s Revenue for the six months ended in Jun. 2023 was $1,186 Mil. Hence, WuXi Biologics (Cayman)'s Days Sales Outstanding for the six months ended in Jun. 2023 was 103.51.

The historical rank and industry rank for WuXi Biologics (Cayman)'s Days Sales Outstanding or its related term are showing as below:

WXXWY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 56.52 Med: 95.45 Max: 116.59
Current: 108.98

During the past 10 years, WuXi Biologics (Cayman)'s highest Days Sales Outstanding was 116.59. The lowest was 56.52. And the median was 95.45.

WXXWY's Days Sales Outstanding is ranked worse than
69.56% of 887 companies
in the Biotechnology industry
Industry Median: 72.66 vs WXXWY: 108.98

WuXi Biologics (Cayman)'s Days Sales Outstanding declined from Jun. 2022 (110.18) to Jun. 2023 (103.51).

WuXi Biologics (Cayman) Days Sales Outstanding Historical Data

The historical data trend for WuXi Biologics (Cayman)'s Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

96.75

116.32

95.70

96.46

111.60

WuXi Biologics (Cayman) Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding														92.24	110.18	116.49	103.51	112.11

Competitive Comparison

For the Biotechnology subindustry, WuXi Biologics (Cayman)'s Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WuXi Biologics (Cayman) Days Sales Outstanding Distribution

For the Biotechnology industry and Healthcare sector, WuXi Biologics (Cayman)'s Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where WuXi Biologics (Cayman)'s Days Sales Outstanding falls into.

WuXi Biologics (Cayman) Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

WuXi Biologics (Cayman)'s Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (490.439	+	667.077)	/	2 )	/	2190.091	*	365
=	578.758					/	2190.091	*	365
=	96.46

WuXi Biologics (Cayman)'s Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (667.077	+	678.037)	/	2 )	/	1185.808	*	365 / 2
=	672.557					/	1185.808	*	365 / 2
=	103.51

WuXi Biologics (Cayman) (OTCPK:WXXWY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

WuXi Biologics (Cayman) Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi Biologics (Cayman) (WuXi Biologics (Cayman)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (OTCPK:WXXWY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

WXIBF:USA 2269:Mexico 02269:Hong Kong 1FW1:Germany 1FW2:Germany

Address

No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092

Website

https://www.wuxibiologics.com

WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 15 billion. North American represented 55.6% of total revenue in 2022. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.